| Patient | William Shakespeare |
|---|---|
| Date of birth | 1564-05-03 |
| Identifiers | MRN HR-RE005-SYN-TD; SSN (made up) 000-05-9036 |
| Document date | 2026-11-01 |
| Author | Rowena Achterberg-Sule, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for six months of tremor of the writing hand in a writer of 51. Concerns: His hand shakes when he writes and when he signs his name, and his pages are getting harder to read; Wants to know whether this is the beginning of something worse, such as Parkinson disease; Wants to keep writing by hand. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Propranolol extended-release 60 mg oral capsule, one capsule by mouth each morning | One capsule each morning | Oral route | 1616-01-26 to 1616-02-23 | completed | S |
| Propranolol extended-release 80 mg oral capsule, one capsule by mouth each morning | One capsule each morning | Oral route | 1616-02-23 | active | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1615-10-20 | Influenza vaccine, 1615-1616 season | completed | S |
| 1608-07-09 | Tdap vaccine | completed | S |
| 1615-10-20 | COVID-19 vaccine, 1615-1616 formula | completed | S |
| 1616-02-16 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1616-02-16 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | A glover, wool dealer, and town official; no tremor or other illness is recorded; cause of death not recorded in the cited source | D (CLM-0002) | |
| sister | Two sisters died in infancy and a third at the age of eight; causes not recorded in the cited source | D (CLM-0002) | |
| natural son | Died at the age of eleven; cause not recorded in the cited source | D (CLM-0003) |
| Concern | Status | Evidence |
|---|---|---|
| His hand shakes when he writes and when he signs his name, and his pages are getting harder to read | active | S |
| Wants to know whether this is the beginning of something worse, such as Parkinson disease | active | S |
| Wants to keep writing by hand | active | S |
Most recent measures: Thyrotropin [Units/volume] in Serum or Plasma 1.6 on 1616-01-12; Sodium [Moles/volume] in Serum or Plasma 139 on 1616-01-12; Potassium [Moles/volume] in Serum or Plasma 4.2 on 1616-01-12; Creatinine [Mass/volume] in Serum or Plasma 0.96 on 1616-01-12; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1611)/1.73 sq M 96 on 1616-01-12; Glucose [Mass/volume] in Serum or Plasma 92 on 1616-01-12; Calcium [Mass/volume] in Serum or Plasma 9.4 on 1616-01-12; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 on 1616-03-23; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 29 on 1616-03-23; Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 49 on 1616-03-23; Hemoglobin [Mass/volume] in Blood 15.1 on 1616-01-12; MCV [Entitic mean volume] in Red Blood Cells by Automated count 99 on 1616-01-12; Platelets [#/volume] in Blood by Automated count 212 on 1616-01-12; Total score [AUDIT] 12 on 1616-01-12; Cholesterol [Mass/volume] in Serum or Plasma 204 on 1616-02-16; Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 on 1616-02-16; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 128 on 1616-02-16; Triglyceride [Mass/volume] in Serum or Plasma 122 on 1616-02-16; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 1616-02-16; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1616-02-16 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Tremor of the writing hand for six months, with shaky, effortful handwriting and spilling from cups; under evaluation | resolved | confirmed | R25.1 | S — Synthetic presenting problem echoing, without asserting, the shaky signatures on his 1616 will (CLM-0006, R); superseded by the diagnosis at the second visit. |
| Essential tremor (MDS 1608 criteria): bilateral upper-limb postural and kinetic tremor, right more than left, for at least three years, worse over six months, without head or voice tremor or other neurological signs; enhanced by alcohol rebound and caffeine; thyroid and metabolic causes excluded | active | confirmed | G25.0 | S — Synthetic modern diagnosis. The shakiness of his signatures is documented as an interpretation (CLM-0006, R, possible); no tremor is documented in his lifetime, and the mercury hypothesis (CLM-0010) is disputed. |
| Hazardous drinking (AUDIT 12; about 24 standard drinks a week with heavier evenings with friends), without an alcohol use disorder; raised GGT | active | confirmed | Z72.89 | S — Synthetic finding. The only historical mention of his drinking is a story written down decades after his death (CLM-0008, R); it is not treated as evidence of his habits. |
| Acute viral upper respiratory infection (common cold) with a low-grade fever, one week after starting propranolol; resolved | resolved | confirmed | J06.9 | S — Synthetic intercurrent illness; it does not assert anything about the fever in John Ward's later story (CLM-0008, R). |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1616-01-12 | Thyrotropin [Units/volume] in Serum or Plasma | 1.6 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 1616-01-12 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1616-01-12 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1616-01-12 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1616-01-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1611)/1.73 sq M | 96 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1616-01-12 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1616-01-12 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1616-01-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 41 | U/L | 7-55 U/L | Normal | S |
| 1616-01-12 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 44 | U/L | 8-48 U/L | Normal | S |
| 1616-01-12 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 84 | U/L | 8-61 U/L | High | S |
| 1616-01-12 | Hemoglobin [Mass/volume] in Blood | 15.1 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1616-01-12 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 99 | fL | 80-100 fL | Normal | S |
| 1616-01-12 | Platelets [#/volume] in Blood by Automated count | 212 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1616-01-12 | Total score [AUDIT] | 12 | {score} | S | ||
| 1616-02-16 | Cholesterol [Mass/volume] in Serum or Plasma | 204 | mg/dL | <=199 mg/dL | High | S |
| 1616-02-16 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=40 mg/dL | Normal | S |
| 1616-02-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 128 | mg/dL | <=129 mg/dL | Normal | S |
| 1616-02-16 | Triglyceride [Mass/volume] in Serum or Plasma | 122 | mg/dL | <=149 mg/dL | Normal | S |
| 1616-02-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
| 1616-02-16 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1616-03-23 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 49 | U/L | 8-61 U/L | Normal | S |
| 1616-03-23 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 | U/L | 7-55 U/L | Normal | S |
| 1616-03-23 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 29 | U/L | 8-48 U/L | Normal | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1616-01-12 | Body height | 175 | cm | S |
| 1616-01-12 | Body weight | 83 | kg | S |
| 1616-01-12 | Body mass index (BMI) [Ratio] | 27.1 | kg/m2 | S |
| 1616-01-12 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1616-01-12 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 1616-01-12 | Heart rate | 80 | /min | S |
| 1616-01-12 | Respiratory rate | 14 | /min | S |
| 1616-01-12 | Body temperature | 36.6 | Cel | S |
| 1616-01-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1616-01-26 | Body height | 175 | cm | S |
| 1616-01-26 | Body weight | 82.6 | kg | S |
| 1616-01-26 | Body mass index (BMI) [Ratio] | 27 | kg/m2 | S |
| 1616-01-26 | Systolic blood pressure | 130 | mm[Hg] | S |
| 1616-01-26 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1616-01-26 | Heart rate | 78 | /min | S |
| 1616-01-26 | Respiratory rate | 14 | /min | S |
| 1616-01-26 | Body temperature | 36.7 | Cel | S |
| 1616-01-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1616-02-02 | Body height | 175 | cm | S |
| 1616-02-02 | Body weight | 82.4 | kg | S |
| 1616-02-02 | Body mass index (BMI) [Ratio] | 26.9 | kg/m2 | S |
| 1616-02-02 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1616-02-02 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1616-02-02 | Heart rate | 70 | /min | S |
| 1616-02-02 | Respiratory rate | 16 | /min | S |
| 1616-02-02 | Body temperature | 37.9 | Cel | S |
| 1616-02-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1616-02-16 | Body height | 175 | cm | S |
| 1616-02-16 | Body weight | 82 | kg | S |
| 1616-02-16 | Body mass index (BMI) [Ratio] | 26.8 | kg/m2 | S |
| 1616-02-16 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1616-02-16 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1616-02-16 | Heart rate | 66 | /min | S |
| 1616-02-16 | Respiratory rate | 14 | /min | S |
| 1616-02-16 | Body temperature | 36.6 | Cel | S |
| 1616-02-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1616-02-23 | Body height | 175 | cm | S |
| 1616-02-23 | Body weight | 81.6 | kg | S |
| 1616-02-23 | Body mass index (BMI) [Ratio] | 26.6 | kg/m2 | S |
| 1616-02-23 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1616-02-23 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1616-02-23 | Heart rate | 64 | /min | S |
| 1616-02-23 | Respiratory rate | 14 | /min | S |
| 1616-02-23 | Body temperature | 36.5 | Cel | S |
| 1616-02-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1616-03-23 | Body height | 175 | cm | S |
| 1616-03-23 | Body weight | 80.8 | kg | S |
| 1616-03-23 | Body mass index (BMI) [Ratio] | 26.4 | kg/m2 | S |
| 1616-03-23 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1616-03-23 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1616-03-23 | Heart rate | 62 | /min | S |
| 1616-03-23 | Respiratory rate | 14 | /min | S |
| 1616-03-23 | Body temperature | 36.6 | Cel | S |
| 1616-03-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1616-01-12 | Primary care visit for six months of tremor of the writing hand in a writer of 51 | finished | S |
| 1616-01-26 | Two-week review of tremor tests, diagnosis, alcohol follow-up, and movement disorders neurology consultation | finished | S |
| 1616-02-23 | Four-week review of propranolol: tremor rating, pulse and blood pressure, drinking, and occupational therapy | finished | S |
| 1616-03-23 | Eight-week review: tremor and writing, propranolol at 80 mg, liver tests, and drinking | finished | S |
| 1616-02-02 | Same-day sick visit for a cold one week after starting propranolol | finished | S |
| 1616-02-16 | Preventive health visit at 51 | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Tremor history and examination with the MDS 1608 classification (rest, postural, and kinetic tremor; distribution; parkinsonism, dystonia, ataxia); TSH, metabolic panel, liver tests, and blood count; a medication, caffeine, and alcohol review | completed | GL-AAN-ET-2011, GL-MDS-TREMOR-2018, GL-MDS-ETRX-2019 | S |
| Movement disorders neurology consultation to confirm the tremor type, exclude early Parkinson disease, and advise on treatment | completed | GL-AAN-ET-2011, GL-MDS-TREMOR-2018, GL-MDS-ETRX-2019 | S |
| Alcohol: AUDIT screening and a brief intervention (feedback, advice, and a goal of no more than 14 drinks a week and 4 on any day); follow-up of drinking at each visit and GGT after eight to ten weeks | completed | GL-USPSTF-ALCOHOL-2018, GL-NIAAA-2005 | S |
| Handwriting sample and Archimedes spiral at each visit; cut coffee to two cups a day, none after midday | completed | GL-AAN-ET-2011, GL-MDS-TREMOR-2018, GL-MDS-ETRX-2019 | S |
| Propranolol extended-release 60 mg each morning, increased by response to 80 mg; pulse and blood pressure at each visit; primidone if propranolol fails or is not tolerated | completed | GL-AAN-ET-2011, GL-MDS-TREMOR-2018, GL-MDS-ETRX-2019, GL-BEERS-2023 | S |
| Occupational therapy for writing: weighted and wide-grip pens, posture and forearm support, slower larger script, and dictation software for long drafts | completed | GL-AAN-ET-2011, GL-MDS-TREMOR-2018, GL-MDS-ETRX-2019 | S |
| Goals-of-care and advance care planning conversation: a named health care agent and a written directive, alongside the will he is preparing | completed | GL-PREV-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Classify the tremor and exclude treatable causes by the second visit | 1616-01-26 | completed | Essential tremor diagnosed; TSH, glucose, calcium, and kidney tests normal; no parkinsonism | S |
| Legible handwriting for a full page and a steady signature | 1616-04-20 | active | TETRAS writing item from 3 to 1.5 and the spiral much steadier on propranolol 80 mg with a weighted pen | S |
| No more than 14 standard drinks a week and no more than 4 on any day | 1616-04-20 | active | Within the limits for ten weeks, about 10 drinks a week for the last five; GGT 84 to 49 U/L | S |
| Resting pulse above 55 without dizziness, wheeze, or fatigue on propranolol | 1616-04-20 | active | Pulse 62 and blood pressure 120/76 mmHg on 80 mg, without side effects | S |